Cargando…
Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model.
In photodynamic therapy (PDT), photosensitisers accumulate somewhat preferentially in malignant tissues; photoactivation with appropriate wavelength of light release toxic molecular species which lead to tumour tissue death. In order to target ovarian cancer with increased specificity, a chlorin-bas...
Autores principales: | Goff, B. A., Blake, J., Bamberg, M. P., Hasan, T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075938/ https://www.ncbi.nlm.nih.gov/pubmed/8883404 |
Ejemplares similares
-
Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model.
por: Goff, B. A., et al.
Publicado: (1994) -
Targeted Therapy With Immunoconjugates for Multiple Myeloma
por: Bruins, Wassilis S. C., et al.
Publicado: (2020) -
EpCAM-Binding DARPins for Targeted Photodynamic Therapy of Ovarian Cancer
por: van den Brand, Dirk, et al.
Publicado: (2020) -
Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives
por: Mercatelli, Daniele, et al.
Publicado: (2018) -
Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer.
por: Duska, L. R., et al.
Publicado: (1997)